A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetes
Background and AimsNeedle injection and needle-free injection were proven effective in improving glycated hemoglobin (HbA1c) in type 2 diabetes mellitus (T2DM) patients. However, it is unclear if needle-free and needle injections of insulin during intensive insulin therapy in hospitalized patients p...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1162176/full |
_version_ | 1827903007414550528 |
---|---|
author | Quanying Wu Mingqun Deng Weihao Wang Shuyi Yu Miao Wang Chao Sun Qi Pan Lixin Guo |
author_facet | Quanying Wu Mingqun Deng Weihao Wang Shuyi Yu Miao Wang Chao Sun Qi Pan Lixin Guo |
author_sort | Quanying Wu |
collection | DOAJ |
description | Background and AimsNeedle injection and needle-free injection were proven effective in improving glycated hemoglobin (HbA1c) in type 2 diabetes mellitus (T2DM) patients. However, it is unclear if needle-free and needle injections of insulin during intensive insulin therapy in hospitalized patients provide similar efficacy and safety benefits.MethodsA self-controlled cross-over study was conducted on 62 patients with T2DM who received intensive long-acting and short-acting insulin injections with or without needles. The 7-point blood glucose test was performed on the 6th day after insulin administration and the injection method switched on the 7th day of hospitalization. The difference was compared in 7-point blood glucose levels.ResultsThe blood glucose levels at fasting (mean difference=-1.09 ± 2.38mmol/L, 95% CI, -1.69 to -0.48, p=0.0007) and post-breakfast (-1.14 ± 3.02mmol/L, 95%CI, -1.91 to -0.37, p=0.004) were better when patients were receiving needle-free injections compared to when receiving a needle injection. Indeed, daily blood glucose fluctuation, which presented as the area under the curve of glycemia, was decreased in needle-free injection periods (-0.3.48 ± 9.64, 95%CI, -5.95 to -1.01, p=0.0065). There was no significant difference in the dose of long-acting insulin between the two injection methods (-0.32 ± 2.69, 95%CI, -0.99 to 0.37, p>0.05). The dose of fast-acting insulin during the needle-free period was lower than that of when patients received needle injections (-1.66 ± 6.45, 95%CI, -3.29 to -0.025, p<0.05). There was no significant difference in satisfaction between the two regimens (-0.59 ± 1.55,95%CI, -0.938 to 0.509, p=0.557), but there was a significant difference in pain experience, favoring needle-free injections (p < 0.001).ConclusionGlycemia was better controlled by needle-free insulin injections in hospitalized T2DM patients subjected to intensive glycemic control. These patients also experienced less pain than when insulin was injected with a needle. |
first_indexed | 2024-03-13T00:07:12Z |
format | Article |
id | doaj.art-d5e7f3621a5f45839dac46e8c1e44c75 |
institution | Directory Open Access Journal |
issn | 1664-2392 |
language | English |
last_indexed | 2024-03-13T00:07:12Z |
publishDate | 2023-07-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Endocrinology |
spelling | doaj.art-d5e7f3621a5f45839dac46e8c1e44c752023-07-13T00:32:10ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-07-011410.3389/fendo.2023.11621761162176A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetesQuanying Wu0Mingqun Deng1Weihao Wang2Shuyi Yu3Miao Wang4Chao Sun5Qi Pan6Lixin Guo7Nursing Department, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, ChinaNursing Department, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, ChinaBackground and AimsNeedle injection and needle-free injection were proven effective in improving glycated hemoglobin (HbA1c) in type 2 diabetes mellitus (T2DM) patients. However, it is unclear if needle-free and needle injections of insulin during intensive insulin therapy in hospitalized patients provide similar efficacy and safety benefits.MethodsA self-controlled cross-over study was conducted on 62 patients with T2DM who received intensive long-acting and short-acting insulin injections with or without needles. The 7-point blood glucose test was performed on the 6th day after insulin administration and the injection method switched on the 7th day of hospitalization. The difference was compared in 7-point blood glucose levels.ResultsThe blood glucose levels at fasting (mean difference=-1.09 ± 2.38mmol/L, 95% CI, -1.69 to -0.48, p=0.0007) and post-breakfast (-1.14 ± 3.02mmol/L, 95%CI, -1.91 to -0.37, p=0.004) were better when patients were receiving needle-free injections compared to when receiving a needle injection. Indeed, daily blood glucose fluctuation, which presented as the area under the curve of glycemia, was decreased in needle-free injection periods (-0.3.48 ± 9.64, 95%CI, -5.95 to -1.01, p=0.0065). There was no significant difference in the dose of long-acting insulin between the two injection methods (-0.32 ± 2.69, 95%CI, -0.99 to 0.37, p>0.05). The dose of fast-acting insulin during the needle-free period was lower than that of when patients received needle injections (-1.66 ± 6.45, 95%CI, -3.29 to -0.025, p<0.05). There was no significant difference in satisfaction between the two regimens (-0.59 ± 1.55,95%CI, -0.938 to 0.509, p=0.557), but there was a significant difference in pain experience, favoring needle-free injections (p < 0.001).ConclusionGlycemia was better controlled by needle-free insulin injections in hospitalized T2DM patients subjected to intensive glycemic control. These patients also experienced less pain than when insulin was injected with a needle.https://www.frontiersin.org/articles/10.3389/fendo.2023.1162176/fullneedle-free injectiondiabetesintensive insulin therapyin hospitalcross-over study |
spellingShingle | Quanying Wu Mingqun Deng Weihao Wang Shuyi Yu Miao Wang Chao Sun Qi Pan Lixin Guo A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetes Frontiers in Endocrinology needle-free injection diabetes intensive insulin therapy in hospital cross-over study |
title | A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetes |
title_full | A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetes |
title_fullStr | A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetes |
title_full_unstemmed | A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetes |
title_short | A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetes |
title_sort | self controlled cross over study of intensive insulin treatment with needle based injection versus needle free injection in hospitalized patients with type 2 diabetes |
topic | needle-free injection diabetes intensive insulin therapy in hospital cross-over study |
url | https://www.frontiersin.org/articles/10.3389/fendo.2023.1162176/full |
work_keys_str_mv | AT quanyingwu aselfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT mingqundeng aselfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT weihaowang aselfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT shuyiyu aselfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT miaowang aselfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT chaosun aselfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT qipan aselfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT lixinguo aselfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT quanyingwu selfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT mingqundeng selfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT weihaowang selfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT shuyiyu selfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT miaowang selfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT chaosun selfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT qipan selfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes AT lixinguo selfcontrolledcrossoverstudyofintensiveinsulintreatmentwithneedlebasedinjectionversusneedlefreeinjectioninhospitalizedpatientswithtype2diabetes |